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Conclusions:
Data collection by SMS results in significantly improved response rates and 48 timeliness of vaccine safety data. Systems which incorporate SMS could be used to more 49 rapidly detect safety signals and promote more rapid public health response to vaccine 50 quality issues. 51 52 53 54
Introduction 57
Vaccine safety programs are fundamental for promoting vaccine uptake in the community, 58 since any perceived vaccine safety issue can undermine confidence in vaccination [1] . 59
Misperceptions of vaccine safety are a common contributor to low immunisation rates [2] [3] [4] [5] [6] . 60
For example, in Western Australia an unexpected spike in adverse events following trivalent 61 influenza vaccination in children in 2010 resulted in an 84% reduction in influenza vaccine 62 uptake in young children [7, 8] . This example serves as a reminder of the necessity of 63 vigilant vaccine safety programs and the importance of rapid signal response. Further, 64 influenza vaccines continually change in antigenic composition to accommodate shifting 65 strains, but are not considered new vaccines and do not undergo the same efficacy and 66 safety studies as new vaccines [9] . Timely collection of vaccine safety data is necessary in 67 order to identify early warning signals and ensure vaccine quality. 68 69 Some vaccine safety surveillance programs incorporate short message service (SMS) 70 communication to monitor adverse events following immunisation (AEFI) details in near real-71 time [10] [11] [12] [13] . While such methods offer rapid data collection and dissemination of results, to 72 date, no study has investigated the potential differences between SMS and telephone 73 interview data collection methods. This study compares SMS with telephone interviews for 74 the purpose of performing vaccine safety surveillance in terms of a) response rate; b) 75 adverse events reported; and c) the timeliness of obtaining data. 76 77
Methods 78
The Follow-up and Active Surveillance of Trivalent influenza vaccine in Mums (FASTMum) 79 program has monitored the safety of pregnant women who receive inactivated TIV in Western 80 Australia since 2012 [14] . Historically, data collection has relied on telephone interviews of 81 vaccinated pregnant women; however, in 2013, SMS was introduced as a method of collecting 82 AEFI information [11] . In 2014, a subset of 344 women were followed up by telephone interview for comparison purposes. All follow-up occurred between 16 and mobile phone number of the vaccinee [11] . At the time of vaccination, women are asked 91 to indicate on these reports whether they give permission to be contacted by telephone or 92 SMS by WA Health for the purposes of monitoring vaccine safety [11] . During the study time 93 period, 2,011 women were reported to WA Health as receiving TIV and consented to follow-94 up. A random sample of women (n=344) was selected to receive a telephone interview seven 95 days post-vaccination using a random number generator. The remaining 1,667 women were 96 followed up by SMS seven days post-vaccination. Of these 1,667 women, 344 were 97 individually matched by brand of TIV received, age group (18-29 years, 30-39 years, or 40-45 98 years), and residence (metropolitan or rural) to a sample of women who received the same 99 questions via SMS. The sample size was powered to detect a ±4% difference between groups 100 at β=.80. 101 102
Data collection 103
For participants in the SMS-group, a text message was sent seven days following 104 vaccination asking: 105 "In the week since your vaccination, did you experience any reaction, fever, or 106 illness? Please reply Y or N." 107 Women who did not reply were sent a second message within 24 hours with the same text. 108
Women who replied "yes" to either message were sent an additional SMS asking them to 109 complete a five minute survey on their mobile phone. Women who did not complete the 110 survey were telephoned to ask about details related to their reaction. The survey asked if they had experienced any of the following: fever, headache, fatigue, rash, swelling, redness, 112 or pain at the injection site, rigors, or convulsions. Women could make multiple selections 113 and were permitted to record additional events in a free text field. At the end of the survey, 114
women were asked if they had visited any doctor, medical centre, after hours clinic, or 115 emergency department regarding their reaction. 116
117
For participants in the telephone-group, a research nurse telephoned the mobile phone of 118 the participant seven days post-vaccination. No SMS messages were sent to women in this 119 group, and all questions in the telephone interview were identical to those of the mobile 120 phone survey. Women were asked by telephone whether they experienced any reaction and 121 women who replied affirmatively were asked about details related to the reaction. Women 122 who did not respond to telephone interview were telephoned again 24 hours later, until a 123 maximum of three contact attempts were made. 124 125
Outcomes measured 126
We were interested in comparing the two methods of collecting vaccine safety data in terms 127 of response rate, reactions reported, and timeliness of the data collection. We defined 128 'response rate' as the proportion of participants who returned a text message in the SMS-129 group or answered a telephone call in the telephone-group. The proportion of women who 130 experienced each reaction included on the surveys was calculated and compared between 131 groups. We also compared response rate to SMS and telephone interview by 132 sociodemographic characteristics. We calculated the time required to collect completed 133 adverse event information for both data collection methods. 134 135
Statistical analysis 136
Data were analysed using SAS version 9.3 (SAS Institute Inc, Sydney, NSW, Australia). 137
Response rates to SMS and telephone interview were compared by sociodemographic 138 subgroups using Cochran Mantel-Haenszel (CMH) chi square tests. The response rates to SMS versus telephone interview were compared overall and by sociodemographic factors by 140 calculating risk ratios (α=.05). Risk ratios were also used to compare the number of women 141 who reported each event by SMS and telephone interview. Independent sample t-tests were 142 used to compare the mean time (in days) required to collect complete AEFI data by SMS 143 and telephone interview. 
Response Rate 156
A total of 310 (90.1%) of women replied to SMS (Figure 1 replied to SMS, replied to the first message (n=277, 89.3%). Of the 38 women who replied to 175 the SMS indicating they had experienced an AEFI, 23 (60.5%) women provided information 176 related to the event: 10 (43.5%) by mobile phone survey and 13 (56.5%) had to be 177 telephoned. The remaining 15 women who indicated they experienced a reaction could not 178 be reached by either telephone interview or SMS. 179 180
Events reported 181
Women in the SMS-group were 59% less likely to report an AEFI compared to women in the 182 telephone-group (RR 0.41; 95% CI 0.29-0.59) ( Table 2 ). When we compared the events 183 reported by women who experienced an AEFI, women in the SMS-group were 81% less 184 likely (RR 0.18, 95% CI 0.09-0.37) to report a local reaction and 64% less likely (RR: 0.36, 185 95% CI 0.05-0.70) to report events not included in the survey ( Table 2 ). Women were just as 186 likely to report fever, headache, fatigue, vomiting, rash, or rigors by SMS or telephone, and 187 no women reported convulsions. Women were just as likely to report having sought medical 188 care for their AEFI by SMS and telephone (RR: 0.45; 95% CI: 0.11-1.85). 189 190
Timeliness of data 191
Collection of AEFI details from SMS participants required significantly less time than 192 telephone participants (Figure 2) ; 95.6% of women in the SMS-group reported complete 193 group. On average, complete AEFI information was obtained from women in the SMS-group 195 within 2.4 hours (95% CI: 2.4-4.8 hours) of follow-up, whereas information was obtained 196 from women in the telephone-group within 2.7 days (95% CI: 2.5-3.0 days)(t: 20.3, p<0.01). 197
The time required to collect information was similar for women who experienced a reaction 198 as those who did not experience a reaction (1.6 days vs 1.3 days, t: -1.03, p=0.30). To our knowledge, this is the first study specifically designed to directly compare SMS with 202 telephone interview for the purpose of AEFI surveillance. Based on our results, an SMS-203 based adverse event monitoring program would detect a similar rate of medically-attended 204 adverse events as a telephone-based system. Data collection by SMS was significantly 205 more rapid and associated with improved response rates over telephone interviews. These 206 results indicate SMS could be used to implement an AEFI monitoring program with the 207 capability for rapid response to safety signals. 208
209
Previous observational studies support our findings, in that response to SMS often exceeds 210 80% [10, 11] and adverse event information can vary when collected by SMS and telephone 211 interview, which is consistent with previous observational studies [11] . Internationally, there 212 is growing evidence supporting the feasibility of SMS as a method of data collection. In the 213 United States, researchers successfully used SMS to monitor the reactogenicity of trivalent 214 influenza vaccine in children over a seven day period [15] . In Sweden, Bexelius et al. [16] 215 compared SMS to standardised telephone interviews for administering three survey 216 questions related to influenza and influenza vaccination. Vaccination data collected by SMS 217 was statistically similar to data collected by telephone interview. A number of other public 218 health systems have further demonstrated the utility of SMS for data collection, including 219 collection of immunisation status [16] , asthma symptoms [17] , irritable bowel syndrome 220 symptoms [18] , Ebolavirus symptoms [19] , and pain outcomes [20] . 221
Our results indicate that SMS can be used as a valuable tool for signal detection; however, 223 some of our findings suggest there are limitations of SMS for AEFI monitoring. First, 224 although 90% of women replied to the initial SMS, 56.5% of women who reported an AEFI 225 via SMS did not respond to the follow-up SMS and had to be telephoned to collect details of 226 the event. These results indicate SMS may not be a complete solution to AEFI information 227 collection. Second, there were some distinct differences in the events reported by SMS 228 compared to telephone. Women surveyed by telephone were more likely to report any 229 adverse event, which can largely be attributed to their increased reporting of injection site 230 reactions. Although not designed to compare the different methods of AEFI data collection, a 231 similar previous investigation found that women followed up by telephone interview were four 232 times as likely to report a local reaction and nearly twice as likely to report a systemic 233 reaction [11] , similar to our results. These findings may suggest that SMS is not suitable for 234
determining an accurate proportion of vaccinees who experience mild, common events, but 235 would instead be suited for monitoring for changes in the safety profile of a vaccine. 236
Regardless of these shortfalls, SMS would detect a safety signal more rapidly compared to 237 telephone interviews. 238
239
While this study provides valuable information which can be used to improve vaccine safety 240 monitoring programs, there were several limitations to our investigation. Due to the 241 population of the routine vaccine safety monitoring program in Western Australia, our sample 242 was restricted to pregnant females and our results may not necessarily apply to other 243 demographic groups. The events reported in this study were self-reported and had not been 244 verified by a health professional. Discrepancies between the rates of AEFI reported by SMS 245 and by telephone interview may be due to response bias. It is plausible that the method of 246 inquiry affected the probability for a vaccinee to recall and report an AEFI. Additional 247 research where reported AEFI are medically verified could provide further information on the 248 use of SMS for data collection. Finally, unlike the SMS group, only 17% of the telephone 249 group were successfully contacted at seven days post-vaccination. As a result, the variation in time required to follow-up by telephone compared to SMS may have biased our results. 251
However, among the women who were successfully contacted by telephone within seven 252 days, 37% reported a reaction, similar to the proportion of all women who were followed up 253 by telephone interview. This indicates that variation in follow-up time is unlikely to be the 254 reason for the differences in AEFI observed in our study. 255 256
Conclusions 257
We compared the use of SMS and telephone interviews for the purposes of collecting AEFI 258 information. Our results show that SMS can be used to improve existing vaccine safety 259 surveillance systems, with certain caveats. Evaluations such as ours are important for 260 informing public health initiatives, considering the current interest in transitioning surveillance 261 systems to mobile phone technology [10-12, 18, 19] . Systems which incorporate SMS as a 262 method of data collection have the potential to more rapidly detect a safety signals and 263 facilitate quick response to identified vaccine quality issues and warrant further exploration. 
